Aerie Pharmaceuticals to Host Investor Day on October 5, 2016
September 28 2016 - 7:30AM
Business Wire
Webcast to Begin at 12:00p.m. Eastern
Time
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), today announced that
the Company will host a live webcast of its Investor Day taking
place on Wednesday, October 5, 2016 at 12:00p.m. ET in New York,
NY.
To view the slide presentation and listen to the webcast please
visit our website at http://investors.aeriepharma.com. The webcast
recording will be archived on the Investor Relations section of
www.aeriepharma.com and will be available for 30 days following the
event.
About Aerie Pharmaceuticals, Inc.
Aerie is a clinical-stage pharmaceutical company focused on the
discovery, development and commercialization of first-in-class
therapies for the treatment of patients with glaucoma and other
diseases of the eye. Aerie's two lead product candidates are
once-daiIy IOP-lowering therapies with novel mechanisms of action
to treat patients with glaucoma or ocular hypertension. The NDA
filing for Rhopressa™ (netarsudil ophthalmic solution) 0.02% was
submitted in the third quarter of 2016. The second product
candidate, Roclatan™ (netarsudil/latanoprost ophthalmic solution)
0.02%/0.005%, which is a fixed dose combination of Rhopressa™ and
widely prescribed PGA latanoprost, currently has two Phase 3
registration trials underway, named Mercury 1 and Mercury 2. If
these trials are successful, a Roclatan™ NDA filing is expected to
take place near year-end 2017. Aerie is also focused on the
development of additional product candidates and technologies in
ophthalmology.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160928005041/en/
Aerie PharmaceuticalsRichard Rubino,
908-947-3540rrubino@aeriepharma.comorBurns McClellan, Inc., on
behalf of Aerie PharmaceuticalsInvestorsAmi Bavishi,
212-213-0006abavishi@burnsmc.comorMediaJustin Jackson,
212-213-0006jjackson@burnsmc.com
Aerie Pharmaceuticals (NASDAQ:AERI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aerie Pharmaceuticals (NASDAQ:AERI)
Historical Stock Chart
From Apr 2023 to Apr 2024